Table 1 Clinical characteristics of 184 patients with lung cancer.

From: Innovative diagnostic approaches for lung cancer: integrating traditional cytology with qPCR for rapid and reliable results

Variables

All patients (n = 184)

G1 (n = 38)

G2 (n = 108)

G3 (n = 38)

P value

Age (years)

    

0.496

Median

64

63

65

64.5

 

Range

27–90

44–79

34–90

27–78

 

Gender, n (%)

    

0.439

Male

114 (62.0)

27 (71.1)

65 (60.2)

22 (57.9)

 

Female

70 (38.0)

11 (28.9)

43 (39.8)

16 (42.1)

 

Clinical stage, n (%)

    

0.479

I

7 (4.6)

1 (3.2)

4 (4.4)

2 (6.3)

 

II

4 (2.6)

2 (6.4)

2 (2.2)

0 (0)

 

III

37 (24.2)

9 (29.0)

18 (20)

10 (31.3)

 

IV

105 (68.6)

19 (61.39)

66 (73.3)

20 (62.5)

 

NA

27

7

14

6

 

Histology types, n (%)

    

0.034

NSCLC: ADC

100 (54.3)

18 (47.4)

68 (63.0)

14 (36.8)

 

NSCLC: SCC

30 (16.3)

5 (13.2)

16 (14.8)

9 (23.7)

 

NSCLC: ASC

2 (1.1)

0 (0)

2 (1.9)

0 (0)

 

SCLC

12 (6.5)

4 (10.5)

3 (2.8)

5 (13.2)

 

NEN

4 (2.2)

1 (2.6)

3 (2.8)

0 (0)

 

Undefined

22 (12.0)

4 (10.5)

12 (11.1)

6 (15.8)

 

Benign

14 (7.6)

6 (15.8)

4 (3.7)

4 (10.5)

 
  1. NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; ADC, adenocarcinoma; SCC, squamous cell carcinoma; ASC, adenosquamous carcinoma; NEN, neuroendocrine neoplasms.